PARQuit Smoking Cessation Intervention for Adults With Serious Mental Illness

Phase 4 Completed 108 enrolled University of California, San Francisco Tobacco Related Disease Research Program · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

This is a research study investigating a smoking cessation program tailored for adults with serious mental illness (SMI). The program uses a Videogame-based Physical (VIP) activity, smoking cessation counseling, and medication (bupropion),

Timeline

Start: 2019-07-08
Primary completion: 2025-07-30
Completion: 2025-07-30

Publications

Whitmore H, Hubbard E, Cooper B, Leutwyler H. Randomized Controlled Trial of a Group-Based Smoking Cessation Intervention for Adults With Serious Mental Illness. Nicotine Tob Res. 2026 May 17:ntag110. doi: 10.1093/ntr/ntag110. Online ahead of print.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Bupropion	Small molecule	—	—

PARQuit Smoking Cessation Intervention for Adults With Serious Mental Illness

Summary

Timeline

Publications

Drugs

Indications